PHBI (Pharmagreen Biotech) Total Operating Expense: $0.56 Mil (TTM As of Jun. 2023)


What is Pharmagreen Biotech Total Operating Expense?

Pharmagreen Biotech PHBI Total Operating Expense is $0.56 Mil as of Jun. 2023.

Pharmagreen Biotech's Total Operating Expense for the three months ended in Jun. 2023 was $0.08 Mil. Pharmagreen Biotech's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was $0.56 Mil.

Pharmagreen Biotech Total Operating Expense Related Terms

Pharmagreen Biotech Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Pharmagreen Biotech's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagreen Biotech Total Operating Expense Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
Total Operating Expense
Get a 7-Day Free Trial 0.67 0.65 0.49 0.75 1.07

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.18 0.18 0.12 0.08

Pharmagreen Biotech Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.56 Mil mean?
Pharmagreen Biotech (PHBI) has a Total Operating Expense of $0.56 Mil as of Jun. 2023. Total operating expense is the primary recurring expense associated with central operations. View historical data on Pharmagreen Biotech and its competitors.
Is Pharmagreen Biotech's Total Operating Expense too high?
Pharmagreen Biotech's current Total Operating Expense is $0.56 Mil.
How does Pharmagreen Biotech's Total Operating Expense compare to DVLP and CSTF?
Pharmagreen Biotech's Total Operating Expense of $0.56 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Pharmagreen Biotech and its competitors. Pharmagreen Biotech's current Total Operating Expense is $0.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagreen Biotech stock overvalued right now?
Pharmagreen Biotech (PHBI) has a current Total Operating Expense of $0.56 Mil. The current Total Operating Expense is $0.56 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Pharmagreen Biotech (PHBI), the current Total Operating Expense is $0.56 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagreen Biotech Business Description

Address 112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.